Finance

Lists
500660:BOM
GlaxoSmithKline Pharmaceuticals Ltd
၂,၅၆၇.၂၅ ₹
+၁.၇၅%
(+၄၄.၂၅) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 500660...
Open
၂,၅၂၇.၂၅ ₹
High
၂,၅၇၂.၄၀ ₹
Low
၂,၅၂၇.၂၅ ₹
Mkt. cap
ဋေ ၄.၃၅ သ
Avg. vol.
၅.၀၃ ထောင်
Volume
၂.၃၇ ထောင်
Dividend
၂.၂၂%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၀.၇၂
52-wk high
၃,၁၂၁.၁၀ ₹
52-wk low
၂,၀၈၈.၀၀ ₹
EPS
၆၃.၀၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
Open
၂,၅၂၇.၂၅ ₹
High
၂,၅၇၂.၄၀ ₹
Low
၂,၅၂၇.၂၅ ₹
Mkt. cap
ဋေ ၄.၃၅ သ
Avg. vol.
၅.၀၃ ထောင်
Volume
၂.၃၇ ထောင်
Dividend
၂.၂၂%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၀.၇၂
52-wk high
၃,၁၂၁.၁၀ ₹
52-wk low
၂,၀၈၈.၀၀ ₹
EPS
၆၃.၀၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
News stories
From web sources and news partners
AskTraders.com
AskTraders.com
·
ပြီးခဲ့သည့် ၅၅ မိနစ်
S&P 500 Can Absorb Fed Hikes, Says UBS CIO After Hot US Inflation
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၀ နာရီ
Michael Burry Warns of a Stock Market ‘Supervolcano’
AOL.com
AOL.com
·
ပြီးခဲ့သည့် ၆ နာရီ
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees၃.၁ ထောင်
Founded၁၉၂၄ နို ၁၃
Headquarters-
Sector-
Last report
၂၀၂၆ ဩ ၃
Fiscal period
Q1 2027
၁၄.၀၀ ₹ / ၁၃.၉၀ ₹
+၀.၇၂%beat
Revenue / Est. (INR)
၉၃၈.၄၄ ဋေ / ၉၁၁.၁၅ ဋေ
+၃.၀၀%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၉၇၉.၉၄ ဋေ
ဋေ ၁.၀၄ ထ
၉၉၅.၃၀ ဋေ
၉၃၈.၄၄ ဋေ
Cost of goods sold
၃၅၅.၅၃ ဋေ
၃၆၃.၈၂ ဋေ
၃၆၈.၅၆ ဋေ
၃၂၇.၉၄ ဋေ
Cost of revenue
၃၅၅.၅၃ ဋေ
၃၆၃.၈၂ ဋေ
၃၆၈.၅၆ ဋေ
၃၂၇.၉၄ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁၃၈.၀၅ ဋေ
၁၅၁.၈၈ ဋေ
၂၉၄.၆၈ ဋေ
၁၅၉.၀၄ ဋေ
Operating expense
၃၀၆.၁၁ ဋေ
၃၂၆.၄၂ ဋေ
၂၈၄.၁၇ ဋေ
၃၃၀.၈၄ ဋေ
Total operating expenses
၆၆၁.၆၄ ဋေ
၆၉၀.၂၄ ဋေ
၆၅၂.၇၃ ဋေ
၆၅၈.၇၈ ဋေ
Operating income
၃၁၈.၃၀ ဋေ
၃၅၁.၀၂ ဋေ
၃၄၂.၅၇ ဋေ
၂၇၉.၆၆ ဋေ
Other non operating income
၃၃.၅၇ ကုဋေ
၃၂.၁၂ ကုဋေ
-၁၀၉.၄၁ ဋေ
၄၃.၇၆ ကုဋေ
EBT including unusual items
၃၅၄.၀၀ ဋေ
၃၉၉.၉၃ ဋေ
၃၇၃.၁၀ ဋေ
၃၂၂.၄၅ ဋေ
EBT excluding unusual items
၃၅၁.၃၆ ဋေ
၃၈၁.၉၅ ဋေ
၂၉၃.၅၁ ဋေ
၃၂၂.၄၅ ဋေ
Income tax expense
၉၆.၅၁ ကုဋေ
၁၀၄.၃၁ ဋေ
၉၅.၂၄ ကုဋေ
၈၅.၂၇ ကုဋေ
Effective tax rate
၂၇.၂၆%
၂၆.၀၈%
၂၅.၅၃%
၂၆.၄၄%
Other operating expenses
၁၅၀.၆၃ ဋေ
၁၅၄.၂၂ ဋေ
-၂၃.၆၈ ကုဋေ
၁၅၅.၉၆ ဋေ
Net income
၂၅၇.၄၉ ဋေ
၂၉၅.၆၂ ဋေ
၂၇၇.၈၆ ဋေ
၂၃၇.၁၈ ဋေ
Net profit margin
၂၆.၂၈%
၂၈.၃၉%
၂၇.၉၂%
၂၅.၂၇%
Earnings per share
-
-
-
၁၄.၀၀
Interest and investment income
-
-
၆၅.၇၃ ကုဋေ
-
Interest expense
-၅.၁၀ သန်း
-၁.၁၉ ကုဋေ
-၆.၁၂ သန်း
-၉.၇၀ သန်း
Net interest expenses
-၅.၁၀ သန်း
-၁.၁၉ ကုဋေ
၆၅.၁၂ ကုဋေ
-၉.၇၀ သန်း
Depreciation and amortization charges
၁၇.၄၃ ကုဋေ
၂၀.၃၂ ကုဋေ
၁၃.၁၇ ကုဋေ
၁၅.၈၄ ကုဋေ
EBITDA
၃၃၄.၇၈ ဋေ
၃၆၀.၆၁ ဋေ
၃၅၂.၁၉ ဋေ
၂၈၉.၂၈ ဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ